Acute promyelocytic leukaemia and acquired α-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients

nork Wassenaar, T., Black, J., Kahl, B., Schwartz, B., Longo, W., Mosher, D., Williams, E.
Argitaratua 2008

Two Diarylurea Electron Transport Inhibitors Reduce Staphylococcus aureus Hemolytic Activity and Protect Cultured Endothelial Cells from Lysis

nork Proctor, R. A., Dalal, S. C., Kahl, B., Brar, D., Peters, G., Nichols, W. W.
Argitaratua 2002

Pharmacodynamic Evaluation of the Activity of Antibiotics against Hemin- and Menadione-Dependent Small-Colony Variants of Staphylococcus aureus in Models of Extracellular (Broth) a...

nork Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., Van Bambeke, F.
Argitaratua 2012

A child with soft-tissue infection and lymphadenitis

nork Froböse, N.J., Masjosthusmann, K., Huss, S., Correa-Martinez, C.L., Mellmann, A., Schuler, F., Kahl, B.C., Wittkowski, H., Schaumburg, F.
Argitaratua izan da New Microbes New Infect (2020)

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience

nork Hong, F., Habermann, T. M., Gordon, L. I., Hochster, H., Gascoyne, R. D., Morrison, V. A., Fisher, R. I., Bartlett, N. L., Stiff, P. J., Cheson, B. D., Crump, M., Horning, S. J., Kahl, B. S.
Argitaratua izan da Ann Oncol (2014)

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

nork Goy, A., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M. J., de Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., Nasta, S., O'Connor, O. A., Shi, H., Boral, A. L., Fisher, R. I.
Argitaratua izan da Ann Oncol (2009)

VcR-CVAD induction chemotherapy followed by maintenance rituximab produces durable remissions in mantle cell lymphoma: a Wisconsin Oncology Network study

nork Chang, J.E., Carmichael, L.L., Kim, K., Peterson, C., Yang, D.T., Traynor, A.M., Werndli, J. E., Huie, M. S., McFarland, T. A., Volk, M., Blank, J., Callander, N.S., Longo, W.L., Kahl, B.S.
Argitaratua izan da Clin Lymphoma Myeloma Leuk (2017)

VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

nork Chang, J. E., Peterson, C., Choi, S., Eickhoff, J. C., Kim, K., Yang, D. T., Gilbert, L. A., Rogers, E. S., Werndli, J. E., Huie, M. S., McFarland, T. A., Volk, M., Blank, J., Callander, N. S., Longo, W. L., Kahl, B. S.
Argitaratua 2011

Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C

nork Erbe, A K, Wang, Wei, Grzywacz, B, Ranheim, E A, Hank, J A, Kim, K, Carmichael, L, Seo, S, Mendonca, E A, Song, Y, Hong, F, Gascoyne, R D, Paietta, E, Horning, S H, Kahl, B, Sondel, P M
Argitaratua 2013

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for Advanced Hodgkin Lymphoma in the Modern Era

nork Diefenbach, C. S., Li, H., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Crump, M., Gascoyne, R. D., Wagner, H., Stiff, P. J., Cheson, B. D., Stewart, D. A., Kahl, B. S., Friedberg, J. W., Blum, K. A., Habermann, T. M., Tuscano, J. M., Hoppe, R. T., Horning, S. J., Advani, R. H.
Argitaratua izan da Br J Haematol (2015)